...
首页> 外文期刊>Medicine. >Familial aggregation of subcutaneous panniculitis-like T cell lymphoma: A case report of monozygotic twin brothers
【24h】

Familial aggregation of subcutaneous panniculitis-like T cell lymphoma: A case report of monozygotic twin brothers

机译:皮下Panniculitis样T细胞淋巴瘤的家族聚集 - 单一孪生兄弟的案例报告

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Rationale: Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare subtype of cutaneous lymphoma, which was first defined as a clinical entity in 1991 as a cytotoxic T-cell lymphoma preferentially infiltrating subcutaneous tissue. Herein, we report 2 patients of SPTCL who are a pair of twin brothers. Patient concerns: The disease afflicted the monozygotic twin brothers at different time with an interval period of 5 years. The older twin brother had disease onset at 27 years of age. In June 2012, he developed prolonged fever accompanied by subcutaneous nodules in the left upper arm and left chest due to unknown origin. The younger twin brother had disease onset at 32 years of age. In June 2017, the younger brother presented with repeated high fever for more than 10 days, accompanied by head distension. Diagnosis: On August 7, 2012, skin biopsy was performed on the lesion of left upper arm of the older twin brother, and then, a diagnosis of subcutaneous panniculitis-like T cell lymphoma (SPTCL) was made. On June 19, 2017, the younger twin brother underwent whole-body fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography for diagnosis. Soon afterwards, abdominal subcutaneous nodule resection and biopsy was performed on June 28, 2018, and the specimen was diagnosed as SPTCL. Interventions: For the older brother, a total of 14 systemic chemotherapy sessions were performed from August 16, 2012, to September 21, 2014. For the younger brother, a total of 9 systemic chemotherapy sessions were performed from July 14, 2017, to March 8, 2018, then he was switched to oral chemotherapy with chidamide twice a week for 6 months. Outcomes: The older twin brother died in March 2015, the younger brother has recovered well and is no longer receiving any treatment Lessons: To the best of our knowledge, twin brothers both having this disease has never been previously reported. Moreover, some of the involved areas are also extremely rare detected by fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography at initial stage. It is beneficial to people to gain some new understanding for SPTCL by this special case and some extremely unusual involved sites in the younger twin brother.
机译:基本原理:皮下Panniculitis样T细胞淋巴瘤(SPTCL)是一种皮肤淋巴瘤的稀有亚型,其首先被定义为1991年的临床实体,作为一种优先渗透皮下组织的细胞毒性T细胞淋巴瘤。在此,我们报告了一对双胞胎兄弟的SPTCL患者。患者担忧:这种疾病在不同时间折磨单卵双胞胎兄弟,间隔为5年。年龄较大的双胞胎兄弟在27岁时患病发作。 2012年6月,他伴随着左上臂的皮下结节和由于未知的原产地,伴随着延长的发烧。年轻的双胞胎兄弟在32岁时疾病发作。 2017年6月,弟弟在10天举行超过10天,伴随着头部的倾向。诊断:2012年8月7日,对较旧的双胞胎兄弟的左上臂的病变进行了皮肤活检,然后制备了皮下Panniculitis-γ样T细胞淋巴瘤(SPTCL)的诊断。 2017年6月19日,年轻的双胞胎兄弟接受了全身氟-18氟脱氧葡萄糖正电子发射断层扫描/计算断层扫描以进行诊断。之后很快,腹部皮下结节切除和活组织检查是在2018年6月28日进行的,并且标本被诊断为SPTCL。干预措施:对于哥哥,总共14个全身化疗会议于2012年8月16日至2014年9月21日进行。对于较年轻的兄弟,共有9个全身化疗会议于2017年7月14日至3月进行2018年8月8日,他每周两次两次与白酰胺切换到口腔化疗6个月。结果:年长的双胞胎兄弟于2015年3月去世,弟弟已经康复,不再接受任何治疗课程:据我们所知,这疾病的双胞胎从未报道过。此外,一些涉及的区域在初始阶段的氟-18氟脱氧葡萄糖正电子断层扫描/计算机断层扫描也非常罕见。对于人们通过这个特殊案件获得对SPTCL的一些新的理解,以及年轻的孪生兄弟的一些非常不寻常的涉及场地。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号